Hay, Kevin A.
University of British Columbia · Fred Hutch Cancer Center
3 papers on CoChatORCID 0000-0002-9398-2677
Most cited papers
- Verified
Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
Gust, J., Hay, K. A., Hanafi, L.-A., Li, D., Myerson, D., Gonzalez-Cuyar, L. F., Yeung, C., Liles, W. C., Wurfel, M., Lopez, J. A., et al. (2017) · Cancer Discovery
CAR-T cell therapy researchBarrier Structure and Function Studies
Cited by 1,400
- Verified
Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor–modified T-cell therapy
Hay, K. A., Hanafi, L.-A., Li, D., Gust, J., Liles, W. C., Wurfel, M. M., López, J. A., Chen, J., Chung, D., Harju-Baker, S., et al. (2017) · Blood
CAR-T cell therapy researchImmunotherapy and Immune Responses
Cited by 1,156
- Verified
The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells
Hirayama, A. V., Gauthier, J., Hay, K. A., Voutsinas, J. M., Wu, Q., Gooley, T., Li, D., Cherian, S., Chen, X., Pender, B. S., et al. (2019) · Blood
CAR-T cell therapy researchLymphoma Diagnosis and Treatment
Cited by 355
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free